11-Dec-14 Medtronic will turn over more than USD900 million in China this year, up from only USD50 million ten years ago. Its China strategy is multi-faceted, involving imports, local R&D, patient education and M&A. Despite this success, the advantage Medtronic - along with other foreign device makers - has carved out, is increasingly under pressure from local players, whose ability to innovate and drive costs down via frugal engineering is creating a new standard of excellence. [image: China Business Review]

10-Dec-14 India’s fast-growing medical devices market is dogged by tax and regulatory anomalies and malpractices, making it difficult for local manufacturers. Good news: These problems will be addressed soon by the Drugs & Cosmetics (Amendment) Bill 2014, which is expected to be passed in the current parliament session. [image: PV Sivakumar_The Hindu Business Line]

05-Dec-14 India produces a third of the world's medicines, mostly in the form of generic drugs. But more than 80% of the raw materials for these drugs are imported from China. That gives its neighbour a virtual monopoly over pricing and supply - so much so that there are now no domestic Indian producers of many essential medicines, a situation that worries the Indian government. [image: The Insider]

28-Nov-14 Taiwan’s medical equipment industry output increased by over 5% in 2014 to USD2.8 billion, driven especially by demand for new and ‘smart’ applications. Demand for Taiwanese medical equipment will continue to increase in 2015, most notably in India. [image: Want China Times]

10-Oct-14 Toshiba has announced its business expansion strategy for Southeast Asia, which includes investing USD1 billion over the next five years, and doubling its current sales to USD7 billion. It is building a new medical equipment plant in Malaysia and has recently positioned healthcare as one of its three main pillars of business. (image: MIS-Asia)